Long noncoding RNAs: Important participants and potential therapeutic targets for myocardial ischaemia reperfusion injury

Clin Exp Pharmacol Physiol. 2020 Nov;47(11):1783-1790. doi: 10.1111/1440-1681.13375. Epub 2020 Aug 11.

Abstract

Myocardial ischaemia reperfusion (I/R) injury is one of the leading causes of coronary artery disease-associated morbidity and mortality. While different strategies have been used to limit I/R injuries, cardiac functions often do not recover to the normal level as anticipated. Recent studies have pointed to important roles of long noncoding RNAs (lncRNAs) in the development of myocardial I/R injury. LncRNA is a class of RNA molecules of more than 200 nucleotides in length which are not translated into proteins. I/R causes dysregulation of lncRNA expression in cardiomyocytes, thereby affecting multiple cellular functions including mitochondrial homeostasis, apoptosis, necrosis and autophagy, suggesting that manipulating lncRNAs may be of great potential in counteracting I/R injury-induced myocardial dysfunctions. In this review, we provide an updated summary on our knowledge about contributions of lncRNAs to the development of I/R injury, with an emphasis on the functional links between several well established cardiac lncRNAs and regulation of cellular outcomes post I/R.

Keywords: apoptosis; autophagy; cardiomyocyte; ischaemia and reperfusion injury; lncRNA; long noncoding RNA; necroptotic cell death.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Mitochondria / metabolism
  • Molecular Targeted Therapy*
  • Myocardial Reperfusion Injury*
  • RNA, Long Noncoding*
  • Signal Transduction / genetics

Substances

  • RNA, Long Noncoding